Magromag (Nitrofurantoin)

Nitrofurantoin is absorbed from the gastrointestinal tract and is rapidly excreted into the urine, where it reaches concentrations that kill bacteria. Inside bacterial cells it is reduced to reactive intermediates that damage DNA, inhibit carbohydrate metabolism and disrupt cell wall synthesis, resulting in a bactericidal effect against common urinary pathogens.

The dose of Magromag is determined by the prescribing clinician based on the patient’s age, renal function and the severity of the infection. Typical adult regimens involve multiple daily doses for a short course, but the exact amount and duration must be individualized and written on the prescription.

Safety data for nitrofurantoin in pregnancy are limited, and the drug is generally avoided during the first trimester and near term unless the benefits clearly outweigh the risks. It is excreted in breast milk, so caution is advised for nursing mothers, and a healthcare provider should assess the risk‑benefit ratio before use.

To order Magromag, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The most common alternative for uncomplicated urinary infections is trimethoprim‑sulfamethoxazole. Nitrofurantoin (Magromag) is often preferred when resistance to trimethoprim‑sulfamethoxazole is high, as it achieves high urinary concentrations and has a different resistance profile. However, nitrofurantoin is contraindicated in patients with poor renal function, whereas trimethoprim‑sulfamethoxazole can be used with dose adjustment.

Magromag should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in humid areas such as bathrooms. No special refrigeration is required for this oral formulation.

Magromag is taken orally, usually with a full glass of water. It can be taken with or without food, but if gastrointestinal upset occurs, taking it with meals may help. Doses should be spaced evenly throughout the day as directed by the prescriber, and the full prescribed course should be completed even if symptoms improve.

Serious adverse reactions to nitrofurantoin include pulmonary toxicity such as interstitial pneumonitis, hepatic injury ranging from enzyme elevation to hepatitis, and hemolytic anemia in patients with glucose‑6‑phosphate dehydrogenase deficiency. Patients should seek immediate medical attention if they experience persistent cough, shortness of breath, jaundice, dark urine, or unexplained fatigue.

Magromag should not be used by individuals with severe renal impairment (creatinine clearance <30 mL/min), known hypersensitivity to nitrofurantoin, or a documented G6PD deficiency due to the risk of hemolysis. Caution is also advised for pregnant women in the first trimester and near delivery, as well as for patients with a history of pulmonary or hepatic disease.